L-(+)-Erythrose

L-Erythrose is a monosaccharide that contains an hydroxyl group on the second carbon atom. It can be synthesized by a synthetic scheme involving glycolaldehyde and hydroxylamine. L-Erythrose has been shown to inhibit the enzyme phosphoglycerate kinase, which converts 2-phosphoglycerate into phosphoenolpyruvate. L-Erythrose has also been shown to inhibit dehydroascorbic acid reductase, which converts dehydroascorbic acid into ascorbic acid, and galactitol reductase, which converts galactitol into D-tagatose. The mutant strain of Escherichia coli K12 that was engineered to produce L-erythrose showed a decreased susceptibility to phage infection and an increased resistance to oxidative stress. In addition, the polyol pathway in E. coli was induced by L-erythrose treatment.Application：L-Erythrose is a rare aldotetrose that have been used as a chirality factor used in QSAR studies of chiral molecules.

Specifictaions: ≥90%, 40% aqueous solution

Specification: MFCD00064377

MDL Number: C4H8O4

Molecular Formula: 120.10

Molecular Weight: 208-567-8

PubChem CID: 5460674

Isomeric SMILES: C([C@@H]([C@@H](C=O)O)O)O

Beilstein Registry Number: 1721697

UPC:

41131808

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

E759680-100mg

CAS:

533-49-3

Product Size:

100mg